Washington, D.C., April 20, 2024 (GLOBE NEWSWIRE) —                                                                         Public Health Alert Congressional and Public Affairs Maria Machuca 202-720-9113FSISpress@usda.gov   FSIS ISSUES PUBLIC HEALTH ALERT FOR GROUND BEEF PRODUCTS

OAKLAND, California, April 19, 2024 (GLOBE NEWSWIRE) — The Peralta Community College District has opened a nationwide search to find ideal candidates to fill four leadership positions that will play

Cerritos, April 19, 2024 (GLOBE NEWSWIRE) — Cerritos, California – Insta Graphic Systems recently concluded its participation at the FESPA Global Print Expo, a renowned international event that assembles the

NORTHBROOK, Ill., April 19, 2024 (GLOBE NEWSWIRE) — Remedium Healthcare Products is proud to announce the launch of NuVeria Labs’ revolutionary Sacral Silicone Dressing, now available for purchase on Amazon,

Kansas City, MO, April 19, 2024 (GLOBE NEWSWIRE) — Today, the American Association of Colleges of Osteopathic Medicine (AACOM) convened a special Friday Forum during it’s Educating Leaders 2024 conference

DALLAS, April 19, 2024 (GLOBE NEWSWIRE) — Asset Entities Inc. (“Asset Entities” or “the Company”) (Nasdaq: ASST), a provider of digital marketing and content delivery services across Discord and other social media

Dublin, April 19, 2024 (GLOBE NEWSWIRE) — FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVERRULES, 2022 BY PERSONS

ETOBICOKE, Ontario, April 18, 2024 (GLOBE NEWSWIRE) — Cleanfarms, a leading force in Canadian sustainable agriculture initiatives, is set to host a pivotal panel discussion on April 26th, tackling the

GREENE, N.Y., April 18, 2024 (GLOBE NEWSWIRE) — For four consecutive years, Forbes has been honoring The Raymond Corporation as one of America’s best midsize employers. The list recognizes employers from

MINNEAPOLIS, April 18, 2024 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (OTCQB: PBLA)(“Panbela”), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer today announces a

LONDON, 18 Apr. 2024 (GLOBE NEWSWIRE) — This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved

Lehi, April 17, 2024 (GLOBE NEWSWIRE) — Lehi, Utah – In a significant advancement in the field of ophthalmology, Waite Vision is proud to announce the availability of the Light

NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) — After two years of research and writing, the long-awaited next thriller from New York Times bestselling author J.D. Barker will be released

Tel Aviv, Israel / Vancouver, Canada, April 17, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “company”), a biotech company focused on discovery and

Continuous Kesimpta® treatment for up to six years showed sustained efficacy in recently diagnosed (≤3 years) treatment-naïve people living with relapsing multiple sclerosis (RMS) in an analysis of the ALITHIOS open-label